BALA CYNWYD, Pa., April 04, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Univar Solutions Inc. (NYSE - UNVR)
Under the terms of the agreement, Univar will be acquired by funds managed by affiliates of Apollo (NYSE – APO) (the “Apollo Funds”) in an all-cash transaction that values the Company at an enterprise value of approximately $8.1 billion. The agreement provides that Univar Solutions shareholders will receive $36.15 per share in cash. The investigation concerns whether the Univar Solutions Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Apollo Funds are paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/univar-solutions-inc-nyse-unvr/.
U.S. Xpress Enterprises, Inc. (NYSE – USX)
Under the terms of the agreement, U.S. Express will be acquired by Knight-Swift Transportation Holdings Inc. (NYSE - KNX) (“Knight-Swift”). U.S. Xpress stockholders will receive $6.15 per share in an all-cash transaction, representing an enterprise value of approximately $808 million.
The investigation concerns whether the U.S. Xpress Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Knight-Swift is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/u-s-xpress-enterprises-inc-nyse-usx/ .
Oak Street Health (NYSE – OSH)
Under the terms of the deal, Oak Street Health will be acquired by CVS Health® (“CVS”) (NYSE - CVS). Oak Street Health stockholders will receive $39.00 per share in an all-cash transaction, representing an enterprise value of approximately $10.6 billion. The investigation concerns whether the Oak Street Health Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether CVS is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/oak-street-health-nyse-osh/.
Seagen Inc. (Nasdaq - SGEN)
Under the terms of the agreement, Seagen will be acquired by Pfizer Inc. (NYSE - PFE). Pfizer will pay $229.00 in cash for each share of Seagen common stock in a deal with an enterprise value of approximately $43 billion. The investigation concerns whether the Seagen Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Pfizer is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/seagen-inc-nasdaq-sgen/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
